Massachusetts Financial Services’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$50M Sell
666,116
-146,631
-18% -$11.6M 0.02% 477
2025
Q4
$64.3M Sell
812,747
-49,846
-6% -$3.75M 0.02% 438
2025
Q3
$56.4M Buy
862,593
+343,409
+66% +$16.8M 0.02% 448
2025
Q2
$20.5M Buy
+519,184
New +$17M 0.01% 612
2024
Q2
Sell
-5,580
Closed -$242K 878
2024
Q1
$242K Sell
5,580
-12
-0.2% -$572 ﹤0.01% 829
2023
Q4
$283K Sell
5,592
-177
-3% -$8.48K ﹤0.01% 822
2023
Q3
$262K Sell
5,769
-20,760
-78% -$856K ﹤0.01% 828
2023
Q2
$1.09M Sell
26,529
-624
-2% -$24K ﹤0.01% 748
2023
Q1
$970K Buy
+27,153
New +$1.02M ﹤0.01% 763
2016
Q2
Sell
-335,242
Closed -$13.6M 864
2016
Q1
$13.6M Buy
335,242
+4,189
+1% +$170K 0.01% 539
2015
Q4
$20.5M Sell
331,053
-43,450
-12% -$2.34M 0.01% 494
2015
Q3
$15.1M Sell
374,503
-560,279
-60% -$29M 0.01% 541
2015
Q2
$53.8M Sell
934,782
-39,869
-4% -$2.53M 0.03% 332
2015
Q1
$62.1M Sell
974,651
-123,017
-11% -$8.35M 0.03% 309
2014
Q4
$67.8M Buy
1,097,668
+62,738
+6% +$3.1M 0.03% 292
2014
Q3
$40.2M Buy
1,034,930
+471,424
+84% +$16.7M 0.02% 387
2014
Q2
$19.4M Buy
563,506
+101,356
+22% +$3.19M 0.01% 540
2014
Q1
$20M Buy
+462,150
New +$22.4M 0.01% 500

Other funds holding IONS

Massachusetts Financial Services's IONS Position: Q1 2026 in Review

Massachusetts Financial Services reduced its Ionis Pharmaceuticals (IONS) stake by 18% in Q1 2026, selling an estimated $11.6M and leaving 666,116 shares worth $50M. The position accounts for 0.02% of the portfolio, ranked #477.

Massachusetts Financial Services first reported a position in IONS in Q1 2014 and has held it in 18 quarters since. The position peaked at $67.8M in Q4 2014. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Massachusetts Financial Services held 666,116 shares of Ionis Pharmaceuticals worth $50M as of Q1 2026.
  • Massachusetts Financial Services sold 146,631 Ionis Pharmaceuticals shares in Q1 2026, an estimated $11.6M.
  • Ionis Pharmaceuticals made up 0.02% of Massachusetts Financial Services's portfolio in Q1 2026, its #477 holding.
  • Massachusetts Financial Services first reported a position in Ionis Pharmaceuticals in Q1 2014 and has held it in 18 quarters since.
  • Massachusetts Financial Services's Ionis Pharmaceuticals position peaked at $67.8M in Q4 2014.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Massachusetts Financial Services's 13F filing for Q1 2026, filed 14 May 2026.